INT2924

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.50
First Reported 1978
Last Reported 2008
Negated 2
Speculated 1
Reported most in Abstract
Documents 11
Total Number 16
Disease Relevance 4.09
Pain Relevance 3.82

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
SCh 2
muscle 1
plaque 1
SND 1
VLG 1
sch (Mus musculus)
Pain Link Frequency Relevance Heat
qutenza 33 99.98 Very High Very High Very High
rapifen 5 99.62 Very High Very High Very High
lidocaine 8 98.48 Very High Very High Very High
Dismenorea 27 98.40 Very High Very High Very High
anesthesia 9 97.08 Very High Very High Very High
halothane 3 90.36 High High
medulla 1 69.44 Quite High
Pain 3 60.24 Quite High
cINOD 5 5.00 Very Low Very Low Very Low
Neurotransmitter 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Ocular Hypertension 13 100.00 Very High Very High Very High
Sleep Disorders 1 99.78 Very High Very High Very High
Dysmenorrhea 27 98.40 Very High Very High Very High
Death 20 97.12 Very High Very High Very High
Ganglion Cysts 9 96.80 Very High Very High Very High
Paralysis 5 96.72 Very High Very High Very High
Infection 180 96.00 Very High Very High Very High
Toxicity 10 94.60 High High
Urological Neuroanatomy 3 93.36 High High
Vibrio Infection 3 90.24 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
No antiviral activity of SCH 16 was noted against Den-2 although Ribavarin showed a dose dependent inhibition of Den-2 plaque formation (Figure 2, Panels C and D).
Neg (No) Positive_regulation (activity) of SCH in plaque
1) Confidence 0.50 Published 2008 Journal Virol J Section Body Doc Link PMC2408923 Disease Relevance 0 Pain Relevance 0
The therapeutic potential of SCH 16 was also evaluated using a peripheral challenge model wherein JEV (50LD50) was injected (200 ?
Positive_regulation (potential) of SCH
2) Confidence 0.50 Published 2008 Journal Virol J Section Body Doc Link PMC2408923 Disease Relevance 0.58 Pain Relevance 0
To determine the in vivo antiviral potential of SCH 16, three groups of mice (4 mice per group) were injected intracerebrally with 30 ?
Positive_regulation (potential) of SCH
3) Confidence 0.50 Published 2008 Journal Virol J Section Body Doc Link PMC2408923 Disease Relevance 0.45 Pain Relevance 0
Understanding the mechanism of action of SCH 16 in relation to JEV replication
Positive_regulation (action) of SCH
4) Confidence 0.50 Published 2008 Journal Virol J Section Body Doc Link PMC2408923 Disease Relevance 0 Pain Relevance 0
To one set of JEV infected monolayer cultures, SCH 16 at non-toxic concentration was added at '0' hour and incubated for 4 hours.
Positive_regulation (incubated) of SCH
5) Confidence 0.44 Published 2008 Journal Virol J Section Body Doc Link PMC2408923 Disease Relevance 0.10 Pain Relevance 0
The purpose of our study was to examine whether the combination of propofol and alfentanil would prevent the increase in IOP due to Sch as well as endotracheal intubation during a rapid sequence induction of anesthesia.
Spec (whether) Positive_regulation (increase) of Sch associated with rapifen, anesthesia and ocular hypertension
6) Confidence 0.43 Published 1996 Journal Anesth. Analg. Section Abstract Doc Link 8831327 Disease Relevance 0.81 Pain Relevance 0.36
In normal muscle, VO2 increased as much as 150% with SCh alone, while with the combination of lidocaine and SCh, VO2 remained unchanged.
Positive_regulation (increased) of SCh in muscle associated with lidocaine
7) Confidence 0.36 Published 1987 Journal Anesth. Analg. Section Abstract Doc Link 3565794 Disease Relevance 0 Pain Relevance 0.71
Dyspareunia was the only sexual variable where the results after surgery revealed no trend favoring SCH.
Neg (no) Positive_regulation (favoring) of SCH associated with dismenorea
8) Confidence 0.27 Published 2002 Journal BMC Womens Health Section Body Doc Link PMC65528 Disease Relevance 0.67 Pain Relevance 0.47
Forty-eight percent (n = 33) of women undergoing a SCH returned the questionnaire, while 39% (n = 27) of those undergoing a TAR chose to participate.
Positive_regulation (undergoing) of SCH
9) Confidence 0.25 Published 2002 Journal BMC Womens Health Section Body Doc Link PMC65528 Disease Relevance 0 Pain Relevance 0
Forty-eight percent (n = 33) of women undergoing a SCH returned the questionnaire, while 39% (n = 27) of those undergoing a TAH chose to participate.
Positive_regulation (undergoing) of SCH
10) Confidence 0.25 Published 2002 Journal BMC Womens Health Section Abstract Doc Link PMC65528 Disease Relevance 0 Pain Relevance 0
After such lesions, CC stimulation produced expiratory apnea and a 30% increase in SChR due to tonic activation of SND.
Positive_regulation (increase) of SChR in SND associated with sleep disorders
11) Confidence 0.18 Published 1994 Journal Am. J. Physiol. Section Abstract Doc Link 8067462 Disease Relevance 0.10 Pain Relevance 0.11
Results suggest that capsaicin causes degeneration in the SCh, VLG, IGL, MPT, and OPT by selective destruction of a subpopulation of retinal ganglion cells with axonal projections to these sites.
Positive_regulation (causes) of SCh in SCh associated with ganglion cysts and qutenza
12) Confidence 0.18 Published 1991 Journal J. Comp. Neurol. Section Abstract Doc Link 1714924 Disease Relevance 0.38 Pain Relevance 0.64
In the children without SCH (group 3) no changes could be observed; following SCH (group 2) the mean concentration increased to 1,610.5 ng X ml-1 after 30 min; additional premedication with dantrolene (group 1) led to a significant reduction of the myoglobin concentration (413.7 ng X ml-1; p = 0.031).
Positive_regulation (increased) of SCH
13) Confidence 0.08 Published 1985 Journal Anaesthesist Section Abstract Doc Link 4073445 Disease Relevance 0 Pain Relevance 0.15
Results suggest that capsaicin causes degeneration in the SCh, VLG, IGL, MPT, and OPT by selective destruction of a subpopulation of retinal ganglion cells with axonal projections to these sites.
Positive_regulation (causes) of SCh in IGL associated with ganglion cysts and qutenza
14) Confidence 0.06 Published 1991 Journal J. Comp. Neurol. Section Abstract Doc Link 1714924 Disease Relevance 0.38 Pain Relevance 0.64
Results suggest that capsaicin causes degeneration in the SCh, VLG, IGL, MPT, and OPT by selective destruction of a subpopulation of retinal ganglion cells with axonal projections to these sites.
Positive_regulation (causes) of SCh in VLG associated with ganglion cysts and qutenza
15) Confidence 0.06 Published 1991 Journal J. Comp. Neurol. Section Abstract Doc Link 1714924 Disease Relevance 0.38 Pain Relevance 0.64
When the rat had the antero-SCH cut, stimulation of the SCH induced LH release but not FSH, and the inhibition on Prl release was pronounced.
Positive_regulation (stimulation) of SCH in SCH
16) Confidence 0.05 Published 1978 Journal Neuroendocrinology Section Abstract Doc Link 569773 Disease Relevance 0.26 Pain Relevance 0.12

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox